Foghorn Therapeutics Inc. (FHTX)
NASDAQ: FHTX
· Real-Time Price · USD
4.86
0.17 (3.62%)
At close: Sep 26, 2025, 3:59 PM
4.87
0.21%
After-hours: Sep 26, 2025, 06:02 PM EDT
Foghorn Therapeutics Revenue
Foghorn Therapeutics reported an annual revenue of $22.6M, reflecting a -33.83% growth. For the quarter ending June 30, 2025, Foghorn Therapeutics generated $7.56M in revenue.
Revenue (ttm)
22.6M
Revenue Growth
-33.83%
Price / Sales Ratio
11.46
Revenue / Employee
201.8K
Employees
112
Market Cap
274.74M
Revenue Chart
History
| Fiscal Year End | Revenue | % Change |
|---|---|---|
| Dec 31, 2024 | 22.6M | -33.83% |
| Dec 31, 2023 | 34.16M | +77.63% |
| Dec 31, 2022 | 19.23M | +1357.77% |
| Dec 31, 2021 | 1.32M | +206.74% |
| Dec 31, 2020 | 430K | +Infinity% |
| Dec 31, 2019 | 0 | n/a |
| Dec 31, 2018 | 0 | n/a |